skip to content

Tomo Šarić holds M.D. and Ph.D. degrees from the University of Zagreb in Croatia. He received his predoctoral training at the Institute for Physiological Chemistry at the University of Hamburg, Germany (with Joachim Seitz), and postdoctoral training at the University of Texas Health Science Center at San Antonio in Texas, USA (with Sydney Shain) and Harvard Medical School in Boston, USA (with Alfred Goldberg). At Harvard he studied the intracellular protein degradation with focus on intracellular proteases acting downstream of proteasome. He discovered the first aminopeptidase localized in the lumen of the endoplasmic reticulum named ERAP1 that is involved in processing of protein antigens for presentation on major histocomaptibility (MHC) class I molecules to T lymphocytes. In 2003 he joined the Center for Physiology and Pathophysiology at the University of Cologne in Germany. His current research activities focus on exploring the potential of pluripotent stem cell derivatives for tissue regeneration, human in vitro disease modelling and drug testing.


Contact: Tomo Saric, M.D., Ph.D.
Institute for Neurophysiology 2nd floor, room 2003
University of Cologne Robert Koch Str. 39
50931 Cologne Germany
Tel. +49-221-478-86686
Fax +49-221-478-3834E-mail: